Clinical and MRI Features of Cerebral Small-Vessel Disease in Type 1 Diabetes

被引:30
作者
Thorn, Lena M. [1 ,2 ,3 ,4 ]
Shams, Sara [5 ,6 ]
Gordin, Daniel [1 ,2 ,3 ,4 ,7 ]
Liebkind, Ron [8 ]
Forsblom, Carol [1 ,2 ,3 ,4 ]
Summanen, Paula [1 ,2 ,3 ,4 ,9 ]
Haegg-Holmberg, Stefanie [1 ,2 ,3 ,4 ]
Tatlisumak, Turgut [8 ,10 ,11 ]
Salonen, Oili [12 ]
Putaala, Jukka [8 ]
Martola, Juha [5 ,6 ,12 ]
Groop, Per-Henrik [1 ,2 ,3 ,4 ,13 ]
机构
[1] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland
[2] Univ Helsinki, Abdominal Ctr Nephrol, Helsinki, Finland
[3] Helsinki Univ Hosp, Helsinki, Finland
[4] Univ Helsinki, Res Programs Unit, Diabet & Obes, Helsinki, Finland
[5] Karolinska Univ Hosp, Karolinska Inst, Stockholm, Sweden
[6] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[7] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA USA
[8] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland
[9] Helsinki Univ Hosp, Dept Ophthalmol, Helsinki, Finland
[10] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci Neurol, Gothenburg, Sweden
[11] Sahlgrenska Univs Hosp, Dept Neurol, Gothenburg, Sweden
[12] Helsinki Univ Hosp, Dept Radiol, Helsinki, Finland
[13] Monash Univ, Cent Clin Sch, Dept Diabet, Melbourne, Vic, Australia
基金
芬兰科学院;
关键词
RISK-FACTORS; MICROBLEEDS; STROKE; RETINOPATHY; PREVALENCE;
D O I
10.2337/dc18-1302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVETo assess the prevalence of cerebral small-vessel disease (SVD) in subjects with type 1 diabetes compared with healthy control subjects and to characterize the diabetes-related factors associated with SVD.RESEARCH DESIGN AND METHODSThis substudy was cross-sectional in design and included 191 participants with type 1 diabetes and median age 40.0 years (interquartile range 33.0-45.1) and 30 healthy age- and sex-matched control subjects. All participants underwent clinical investigation and brain MRIs, assessed for cerebral SVD.RESULTSCerebral SVD was more common in participants with type 1 diabetes than in healthy control subjects: any marker 35% vs. 10% (P = 0.005), cerebral microbleeds (CMBs) 24% vs. 3.3% (P = 0.008), white matter hyperintensities 17% vs. 6.7% (P = 0.182), and lacunes 2.1% vs. 0% (P = 1.000). Presence of CMBs was independently associated with systolic blood pressure (odds ratio 1.03 [95% CI 1.00-1.05], P = 0.035).CONCLUSIONSCerebral SVD, CMBs in particular, is more common in young people with type 1 diabetes compared with healthy control subjects.
引用
收藏
页码:327 / 330
页数:4
相关论文
共 50 条
  • [41] Risk factors for intracerebral hemorrhage in small-vessel disease and non-small-vessel disease etiologies-an observational proof-of-concept study
    Arndt, Philipp
    Chahem, Christian
    Luchtmann, Michael
    Kuschel, Jan-Niklas
    Behme, Daniel
    Pfister, Malte
    Neumann, Jens
    Goertler, Michael
    Doerner, Marc
    Pawlitzki, Marc
    Jansen, Robin
    Meuth, Sven G.
    Vielhaber, Stefan
    Henneicke, Solveig
    Schreiber, Stefanie
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [42] Brachial-Ankle Pulse Wave Velocity is Related to the Total Cerebral Small-Vessel Disease Score in an Apparently Healthy Asymptomatic Population
    Liu, Tiantian
    Liu, Yuanyuan
    Wang, Shuhua
    Du, Xiaolong
    Zheng, Zhaofeng
    Wang, Ning
    Hou, Xunyao
    Shen, Chao
    Chen, Jian
    Liu, Xueping
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (11)
  • [43] Impaired dynamic cerebral autoregulation is associated with the severity of neuroimaging features of cerebral small vessel disease
    Liu, Zhaojun
    Ma, Hongyin
    Guo, Zhen-Ni
    Wang, Le
    Qu, Yang
    Fan, Lei
    Liu, Xingliang
    Liu, Jie
    Zhu, Yuanyuan
    Yang, Yi
    CNS NEUROSCIENCE & THERAPEUTICS, 2022, 28 (02) : 298 - 306
  • [44] Intracranial vessel wall lesions on 7T MRI and MRI features of cerebral small vessel disease: The SMART-MR study
    Zwartbol, Maarten H. T.
    van der Kolk, Anja G.
    Kuijf, Hugo J.
    Witkamp, Theo D.
    Ghaznawi, Rashid
    Hendrikse, Jeroen
    Geerlings, Mirjam, I
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (06) : 1219 - 1228
  • [45] Progression of MRI markers in cerebral small vessel disease: Sample size considerations for clinical trials
    Benjamin, Philip
    Zeestraten, Eva
    Lambert, Christian
    Ster, Irina Chis
    Williams, Owen A.
    Lawrence, Andrew J.
    Patel, Bhavini
    MacKinnon, Andrew D.
    Barrick, Thomas R.
    Markus, Hugh S.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 (01) : 228 - 240
  • [46] Clinical management of cerebral small vessel disease: a call for a holistic approach
    Clancy Una
    Appleton Jason P.
    Arteaga Carmen
    Doubal Fergus N.
    Bath Philip M.
    Wardlaw Joanna M.
    中华医学杂志英文版, 2021, 134 (02) : 127 - 142
  • [47] Clinical management of cerebral small vessel disease: a call for a holistic approach
    Clancy, Una
    Appleton, Jason P.
    Arteaga, Carmen
    Doubal, Fergus N.
    Bath, Philip M.
    Wardlaw, Joanna M.
    CHINESE MEDICAL JOURNAL, 2021, 134 (02) : 127 - 142
  • [48] Cerebral small vessel disease: a review of clinical, radiological, and histopathological phenotypes
    Moran, Chris
    Phan, Thanh G.
    Srikanth, Velandai K.
    INTERNATIONAL JOURNAL OF STROKE, 2012, 7 (01) : 36 - 46
  • [49] The clinical manifestations and pathophysiology of cerebral small vessel disease
    Zhang, Ai-Juan
    Yu, Xin-Jun
    Wang, Mei
    NEUROSCIENCE BULLETIN, 2010, 26 (03) : 257 - 264
  • [50] Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden
    Staals, Julie
    Makin, Stephen D. J.
    Doubal, Fergus N.
    Dennis, Martin S.
    Wardlaw, Joanna M.
    NEUROLOGY, 2014, 83 (14) : 1228 - 1234